scisparc.com - SPRC Company Value to Revenue

scisparc.com (SPRC) - corporate logo

The absence of commercial revenue due to the clinical testing stage has created a high dependence on investments, which confirms the business valuation relative to revenue for SciSparc Ltd (SPRC). The value 9073.53 reflects the most recent metric value. Meanwhile, steady demand for autism therapy isolates the company from macroeconomic trends, while a strong neuroscience team ensures the preservation of key scientific competencies.

SPRC SciSparc Ltd: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

SciSparc Ltd. - analytical breakdowns and key metrics (SPRC)

- market price and analyst price targets:
Initial company analysis:SciSparc Ltd SPRC
Brand item of SciSparc

SciSparc Ltd (SPRC) potential for monopoly dominance in CNS therapy lays the foundation for a high market premium, which this ratio reflects. The metric compares the total enterprise value (equity plus net debt) to sales volume, eliminating the impact of leverage on the fundamental valuation. A sharp deviation of the enterprise value-to-revenue ratio from industry norms warns of an overheated asset and the risk of a correction should revenue growth rates slow.